In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults
With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
type-II diabetes drug
Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination drug for type-II diabetes in…
The company has launched this FDC under the brand name Zita Plus Pio, which contains Teneligliptin (20 mg) + Pioglitazone (15 mg),…